5 highlights in stroke research in recognition of World Stroke Day
Click Here to Manage Email Alerts
Tuesday, Oct. 29 is World Stroke Day, which aims to raise awareness for the treatment and prevention of stroke. In recognition, Healio presents recent highlights in stroke research.
Low LDL, triglycerides increase stroke risk in women
Women with LDL levels below 70 mg/dL and low triglyceride levels had increased risk for hemorrhagic stroke, according to a study published in Neurology. Read more
Aspirin, rivaroxaban similar for recurrent stroke prevention in certain patients
In patients with embolic stroke of undetermined source and carotid atherosclerosis, aspirin and rivaroxaban were equally effective at preventing recurrent stroke, but aspirin was safer, according to new data from the NAVIGATE ESUS trial. Read more
Sleep duration may be predictive of cardiometabolic risk factors, cerebrovascular disease mortality
Sleep duration was found to be a significant predictor of cardiometabolic risk factors and cerebrovascular disease mortality as well as cancer mortality. Read more
COMPASS: Low-dose rivaroxaban plus aspirin confers reduced embolic stroke risk
According to new data from the COMPASS trial, patients with systemic atherosclerosis assigned low-dose rivaroxaban plus aspirin had reduced risk for cardioembolic stroke and embolic stroke of undetermined origin compared with patients assigned aspirin alone. Read more
LDL below 70 mg/dL increases hemorrhagic stroke risk
Patients with LDL concentrations less than 70 mg/dL had an increased risk for intracerebral hemorrhage, which became nonsignificant once LDL levels surpassed 70 mg/dL, according to a study published in Neurology. Read more